Findings reveal that blocking CD14 alleviates pain and disability in osteoarthritis, suggesting therapeutic potential.
Our results strongly support that targeting synovial and fat pad inflammation through blockade of CD14 can safely ameliorate OA pain and disability after a pre-disposing injury.
No takes yet. Share an insight, caveat, or question.
Burt et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: